U.S. health regulators on Wednesday approved Arena Pharmaceuticals Inc's pill to treat obesity, making it the first new weight-loss drug in 13 years as public health advocates push for new solutions to the nation's growing obesity epidemic.From the insert: Belviq is a serotonin 2C receptor agonist.
It's another antidepressant.
